Literature DB >> 7521365

The role of the Fas lytic pathway in a perforin-less CTL hybridoma.

C M Walsh1, A A Glass, V Chiu, W R Clark.   

Abstract

The murine CTL hybridoma PMMI has been shown by the most sensitive techniques to be devoid of perforin. We thus used PMMI activated with PMA and ionomycin, to investigate possible alternate lytic pathways in CTLs in the absence of perforin. We found that PMMI is equipped with membrane TNF-alpha as a potential lytic mechanism, but TNF-alpha is unlikely to be involved in acute (4 h) lytic reactions. On the other hand, PMMI readily lyses target cells expressing the gene for the Fas Ag, but does not lyse target cells expressing fas antisense DNA. The generation of fas-dependent lysis required protein synthesis in PMMI, but target cell protein synthesis was not required for lysis. Lysis of Fas-positive target cells by PMMI was accompanied by DNA fragmentation, and both lysis and DNA fragmentation were blocked by inhibition of protein synthesis in the effector cell. We find the relative extent and kinetics of fas-dependent lysis and DNA fragmentation indistinguishable from that seen in "classical" CTL lytic assays. Both fas- and perforin-dependent lysis were blocked by inhibitors of poly(ADP) ribosylation. We found very little difference in the sequence of events in target cells lysed by the fas pathway compared with the classical (probably perforin) lytic pathway. Given the widespread distribution of fas, particularly in hematopoietic target cells, caution may be required in interpreting the relationship between parameters such as DNA fragmentation and 51Cr-release solely on the basis of the granule exocytosis model.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7521365

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

1.  Cytotoxic T lymphocyte perforin and Fas ligand working in concert even when Fas ligand lytic action is still not detectable.

Authors:  David Hassin; Orit G Garber; Avihai Meiraz; Yael S Schiffenbauer; Gideon Berke
Journal:  Immunology       Date:  2011-03-29       Impact factor: 7.397

2.  Proteasome regulation of activation-induced T cell death.

Authors:  H Cui; K Matsui; S Omura; S L Schauer; R A Matulka; G E Sonenshein; S T Ju
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

Review 3.  Targeting of peripheral blood T lymphocytes.

Authors:  R L Bolhuis; H R Hoogenboom; J W Gratama
Journal:  Springer Semin Immunopathol       Date:  1996

4.  Immune privilege and FasL: two ways to inactivate effector cytotoxic T lymphocytes by FasL-expressing cells.

Authors:  Jie-Hui Li; Dalia Rosen; Paul Sondel; Gideon Berke
Journal:  Immunology       Date:  2002-03       Impact factor: 7.397

5.  Fas-dependent CD4+ cytotoxic T-cell-mediated pathogenesis during virus infection.

Authors:  A J Zajac; D G Quinn; P L Cohen; J A Frelinger
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

6.  Human lymphocyte apoptosis after exposure to influenza A virus.

Authors:  J E Nichols; J A Niles; N J Roberts
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

7.  Immune responses to intramuscular administration of alipogene tiparvovec (AAV1-LPL(S447X)) in a phase II clinical trial of lipoprotein lipase deficiency gene therapy.

Authors:  Valerie Ferreira; Jaap Twisk; Karin Kwikkers; Eleonora Aronica; Diane Brisson; Julie Methot; Harald Petry; Daniel Gaudet
Journal:  Hum Gene Ther       Date:  2014-02-28       Impact factor: 5.695

8.  Defining the mechanism(s) of protection by cytolytic CD8 T cells against a cryptic epitope derived from a retroviral alternative reading frame.

Authors:  Melanie R Rutkowski; On Ho; William R Green
Journal:  Virology       Date:  2009-06-18       Impact factor: 3.616

9.  Structural and functional consequences of alveolar cell recognition by CD8(+) T lymphocytes in experimental lung disease.

Authors:  R I Enelow; A Z Mohammed; M H Stoler; A N Liu; J S Young; Y H Lou; T J Braciale
Journal:  J Clin Invest       Date:  1998-11-01       Impact factor: 14.808

10.  Mitogen-activated protein kinase-mediated Fas apoptotic signaling pathway.

Authors:  E Goillot; J Raingeaud; A Ranger; R I Tepper; R J Davis; E Harlow; I Sanchez
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.